Related Experiment Videos
Immunogenetics of polymyalgia rheumatica
L I Sakkas1, N Loqueman, G S Panayi
1Division of Medicine, UMDS, Guy's Hospital, London.
British Journal of Rheumatology
|October 1, 1990
Summary
Polymyalgia rheumatica (PMR) may be linked to immune system genes. This study found a strong association between HLA-DR4 and PMR susceptibility, suggesting it’s a key genetic factor.
Area of Science:
- Immunogenetics
- Rheumatology
Background:
- Polymyalgia rheumatica (PMR) is suspected to be an immune-mediated condition.
- Genetic factors, particularly those related to the immune system, are being investigated for their role in PMR pathogenesis.
Purpose of the Study:
- To investigate the association of specific immune system genes with polymyalgia rheumatica.
- To determine if HLA class II genes, immunoglobulin switch regions, or T-cell receptor (TcR) genes are susceptibility factors for PMR.
Main Methods:
- Southern blot analysis was employed to examine the genetic variations.
- The study focused on HLA class II genes (DR, DQA, DQB), immunoglobulin heavy chain switch regions (mu and alpha 1), and T-cell receptor (TcR) genes (alpha, beta, gamma).
Main Results:
- A significantly increased frequency of HLA-DR4 specificity was observed in PMR patients compared to controls (67.4% vs. 30.3%, P = 0.00017).
- No significant associations were found with DQA, DQB genes, immunoglobulin switch regions, or TcR alpha, beta, and gamma genes.
Conclusions:
- HLA-DR4 appears to be a significant genetic susceptibility factor for polymyalgia rheumatica.
- Further research is warranted to fully understand the roles of immunoglobulin (Ig) and T-cell receptor (TcR) genes in PMR.